Dihydrofluoxymesterone (developmental code name U-7265) is an
androgen and
anabolic steroid
Anabolic steroids, also known more properly as anabolic–androgenic steroids (AAS), are steroidal androgens that include natural androgens like testosterone (medication), testosterone as well as synthetic androgens that are structurally related ...
(AAS) which was never marketed.
It was assessed in the treatment of
breast cancer in women in at least one
clinical study in the 1970s and showed effectiveness similar to that of other AAS.
The drug is the
5α-reduced analogue and
metabolite
In biochemistry, a metabolite is an intermediate or end product of metabolism.
The term is usually used for small molecules. Metabolites have various functions, including fuel, structure, signaling, stimulatory and inhibitory effects on enzymes, c ...
of
fluoxymesterone.
See also
*
Oxofluoxymesterone
References
5α-Reduced steroid metabolites
Abandoned drugs
Cyclohexanols
1-Methylcyclopentanols
Androgens and anabolic steroids
Androstanes
Hepatotoxins
Hormonal antineoplastic drugs
Human drug metabolites
Ketones
Organofluorides
{{Genito-urinary-drug-stub